Related references
Note: Only part of the references are listed.Surgical treatment of liver metastasis of gastric cancer: a retrospective multicenter cohort study (KSCC1302)
Eiji Oki et al.
GASTRIC CANCER (2016)
Gastric adenocarcinoma with para-aortic lymph node metastasis: a borderline resectable cancer?
Yasuhiro Kodera et al.
SURGERY TODAY (2015)
Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2014)
Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study)
G. Folprecht et al.
ANNALS OF ONCOLOGY (2014)
Induction of a Pathological Complete Response by Four Courses of Neoadjuvant Chemotherapy for Gastric Cancer: Early Results of the Randomized Phase II COMPASS Trial
Takaki Yoshikawa et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para- aortic lymph node dissection for gastric cancer with extensive lymph node metastasis
A. Tsuburaya et al.
BRITISH JOURNAL OF SURGERY (2014)
Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials
F. Coccolini et al.
EJSO (2014)
Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib - Analysis of prognostic factors (EORTC-STBSG collaborative study)
S. Bauer et al.
EJSO (2014)
Defined criteria for resectability improves rates of secondary resection after systemic therapy for liver limited metastatic colorectal cancer
Robert P. Jones et al.
EUROPEAN JOURNAL OF CANCER (2014)
Survival prolongation after treatment failure of first-line chemotherapy in patients with advanced gastric cancer: combined analysis of the Japan Clinical Oncology Group Trials JCOG9205 and JCOG9912
Atsuo Takashima et al.
GASTRIC CANCER (2014)
Surgical resection of hepatic metastasis from gastric cancer: a review and new recommendation in the Japanese gastric cancer treatment guidelines
Yasuhiro Kodera et al.
GASTRIC CANCER (2014)
Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association
Hideaki Shimada et al.
GASTRIC CANCER (2014)
Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START)
Wasaburo Koizumi et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2014)
PEAK: A Randomized, Multicenter Phase II Study of Panitumumab Plus Modified Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX6) or Bevacizumab Plus mFOLFOX6 in Patients With Previously Untreated, Unresectable, Wild-Type KRAS Exon 2 Metastatic Colorectal Cancer
Lee S. Schwartzberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Impact of Maximal Cytoreductive Surgery Plus Regional Heated Intraperitoneal Chemotherapy (HIPEC) on Outcome of Patients With Peritoneal Carcinomatosis of Gastric Origin: Results of the GYMSSA Trial
Udo Rudloff et al.
JOURNAL OF SURGICAL ONCOLOGY (2014)
Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial
Julien Taieb et al.
LANCET ONCOLOGY (2014)
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
Volker Heinemann et al.
LANCET ONCOLOGY (2014)
Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trial
Harpreet Wasan et al.
LANCET ONCOLOGY (2014)
An Open-Label Phase II Study Evaluating the Safety and Efficacy of Ramucirumab Combined With mFOLFOX-6 as First-Line Therapy for Metastatic Colorectal Cancer
Rocio Garcia-Carbonero et al.
ONCOLOGIST (2014)
Role of stenting in the palliation of gastroesophageal junction cancer: A brief review
Theodoros E. Pavlidis et al.
WORLD JOURNAL OF GASTROINTESTINAL SURGERY (2014)
An automated spring-loaded needle for endoscopic ultrasound-guided abdominal paracentesis in cancer patients
Rei Suzuki et al.
WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY (2014)
Clinical significance of palliative gastrectomy on the survival of patients with incurable advanced gastric cancer: a systematic review and meta-analysis
Jingxu Sun et al.
BMC CANCER (2013)
A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S-1 for treatment of gastric cancer with macroscopic peritoneal metastasis
Hironori Yamaguchi et al.
CANCER (2013)
Phase II trial of paclitaxel and cisplatin as neoadjuvant chemotherapy for locally advanced gastric cancer
Akira Tsuburaya et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Overview of Adjuvant and Neoadjuvant Therapy for Resectable Gastric Cancer in the East
Kazumasa Fujitani
DIGESTIVE SURGERY (2013)
Hepatic resection for synchronous hepatic metastasis from gastric cancer
J. -L. Qiu et al.
EJSO (2013)
Combination of cisplatin/S-1 in the treatment of patients with advanced gastric or gastroesophageal adenocarcinoma: Results of noninferiority and safety analyses compared with cisplatin/5-fluorouracil in the First-Line Advanced Gastric Cancer Study
J. A. Ajani et al.
EUROPEAN JOURNAL OF CANCER (2013)
Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study
Kensei Yamaguchi et al.
GASTRIC CANCER (2013)
Intermittent Versus Continuous Androgen Deprivation Treatment of Prostate Cancer
Jianhong Zhu et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Neoadjuvant chemotherapy for gastric cancer: A meta-analysis of randomized, controlled trials
Yi Liao et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Outcomes of surgery aiming at curative resection in good responder to induction chemotherapy for gastric cancer with distant metastases
Dong-Seok Han et al.
JOURNAL OF SURGICAL ONCOLOGY (2013)
Phase II study of preoperative chemotherapy with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210)
Yoshiaki Iwasaki et al.
JOURNAL OF SURGICAL ONCOLOGY (2013)
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
Axel Grothey et al.
LANCET (2013)
Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial
Yasuhide Yamada et al.
LANCET ONCOLOGY (2013)
Management of gastric cancer in Asia: resource-stratified guidelines
Lin Shen et al.
LANCET ONCOLOGY (2013)
Adjuvant surgery for advanced extrahepatic cholangiocarcinoma
Yukio Oshiro et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Posttherapy Nodal Status, Not Graded Histologic Response, Predicts Survival after Neoadjuvant Chemotherapy for Advanced Gastric Cancer
Kazumasa Fujitani et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Pilot Feasibility Study of Neoadjuvant Chemoradiotherapy with S-1 in Patients with Locally Advanced Gastric Cancer Featuring Adjacent Tissue Invasion or JGCA Bulky N2 Lymph Node Metastases
Tatsushi Inoue et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Effective palliation and quality of life outcomes in studies of surgery for advanced, non-curative gastric cancer: a systematic review
Alyson L. Mahar et al.
GASTRIC CANCER (2012)
Phase II trial of combined treatment consisting of preoperative S-1 plus cisplatin followed by gastrectomy and postoperative S-1 for stage IV gastric cancer
Seiji Satoh et al.
GASTRIC CANCER (2012)
Long-term follow up of patients who were positive for peritoneal lavage cytology: final report from the CCOG0301 study
Yasuhiro Kodera et al.
GASTRIC CANCER (2012)
A Phase II Study of Systemic Chemotherapy with Docetaxel, Cisplatin, and S-1 (DCS) Followed by Surgery in Gastric Cancer Patients with Extensive Lymph Node Metastasis: Japan Clinical Oncology Group Study JCOG1002
Hiroshi Katayama et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2012)
Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Biomarker Evaluation From the AVAGAST Randomized Phase III Trial
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Long-term outcomes after surgical resection for gastric cancer liver metastasis: an analysis of 64 macroscopically complete resections
Nobuyuki Takemura et al.
LANGENBECKS ARCHIVES OF SURGERY (2012)
Non-curative gastric resection for patients with stage 4 gastric cancer-a single center experience and current review of literature
Yves Dittmar et al.
LANGENBECKS ARCHIVES OF SURGERY (2012)
New Japanese classifications and treatment guidelines for gastric cancer: revision concepts and major revised points
Takeshi Sano et al.
GASTRIC CANCER (2011)
Japanese Gastric Cancer Association Task Force for Research Promotion: clinical utility of 18F-fluoro-2-deoxyglucose positron emission tomography in gastric cancer. A systematic review of the literature
Hideaki Shimada et al.
GASTRIC CANCER (2011)
Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002)
Hiroyuki Narahara et al.
GASTRIC CANCER (2011)
Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study
Atsushi Ohtsu et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The Roles of Surgical Oncologists in the New Era - Minimally Invasive Surgery for Early Gastric Cancer and Adjuvant Surgery for Metastatic Gastric Cancer
Kazuhiro Yoshida et al.
PATHOBIOLOGY (2011)
Prognostic Significance of Free Peritoneal Tumor Cells in the Peritoneal Cavity Before and After Neoadjuvant Chemotherapy in Patients with Gastric Carcinoma Undergoing Potentially Curative Resection
Sylvie Lorenzen et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Positive Peritoneal Cytology in Patients with Gastric Cancer: Natural History and Outcome of 291 Patients
James J. Mezhir et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer
Yasushi Sato et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
Combination therapy with docetaxel and S-1 as a first-line treatment in patients with advanced or recurrent gastric cancer: a retrospective analysis
Kazuaki Tanabe et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2010)
Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial
Y. -K. Kang et al.
ANNALS OF ONCOLOGY (2009)
Induction Chemotherapy with S-1 Plus Cisplatin Followed by Surgery for Treatment of Gastric Cancer with Peritoneal Dissemination
Hiroshi Okabe et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Patients With Initially Unresectable Colorectal Liver Metastases: Is There a Possibility of Cure?
Rene Adam et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction
M. Dank et al.
ANNALS OF ONCOLOGY (2008)
Randomized controlled trial comparing gastrectomy plus chemotherapy with chemotherapy alone in advanced gastric cancer with a single non-curable factor: Japan clinical oncology group study JCOG 0705 and korea gastric cancer association study KGCA01
Kazumasa Fujitani et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2008)
S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
Wasaburo Koizumi et al.
LANCET ONCOLOGY (2008)
Capecitabine and oxaliplatin for advanced esophagogastric cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy
Rene Adam et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Surgery of residual disease following molecular-targeted therapy with imatinib mesylate in advanced/metastatic GIST
Alessandro Gronchi et al.
ANNALS OF SURGERY (2007)
Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: A report of the V325 study group
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Sivelestat, a specific neutrophil elastase inhibitor, suppresses the growth of gastric carcinoma cells by preventing the release of transforming growth factor-α
Yoshiyuki Wada et al.
CANCER SCIENCE (2006)
Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors
Chandrajit P. Raut et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate
P Rutkowski et al.
JOURNAL OF SURGICAL ONCOLOGY (2006)
Phase II study of docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer
Kazuhiro Yoshida et al.
CLINICAL CANCER RESEARCH (2006)
Resection of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment with imatinib
S Bauer et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
OncoSurge: A strategy for improving resectability with curative intent in metastatic colorectal cancer
GJ Poston et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer
T Nakamura et al.
AMERICAN JOURNAL OF SURGERY (2004)
XELOX (capecitabine plus oxaliplatin):: Active first-line therapy for patients with metastatic colorectal cancer
J Cassidy et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European organization for research and treatment of cancer gastrointestinal tract cancer cooperative group
U Vanhoefer et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
